Annual Working Capital
$61.07 M
-$52.13 M-46.05%
31 December 2023
Summary:
Xeris Biopharma Holdings annual working capital is currently $61.07 million, with the most recent change of -$52.13 million (-46.05%) on 31 December 2023. During the last 3 years, it has fallen by -$62.93 million (-50.75%). XERS annual working capital is now -50.75% below its all-time high of $124.00 million, reached on 31 December 2020.XERS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$71.79 M
-$23.07 M-24.32%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly working capital is currently $71.79 million, with the most recent change of -$23.07 million (-24.32%) on 30 September 2024. Over the past year, it has increased by +$774.00 thousand (+1.09%). XERS quarterly working capital is now -48.74% below its all-time high of $140.04 million, reached on 31 March 2019.XERS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | +1.1% |
| 3 y3 years | -50.8% | -17.6% |
| 5 y5 years | -43.3% | -18.6% |
XERS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.8% | at low | -36.6% | +17.6% |
| 5 y | 5 years | -50.8% | +1.5% | -47.3% | +19.4% |
| alltime | all time | -50.8% | +99.3% | -48.7% | +83.2% |
Xeris Biopharma Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $71.79 M(-24.3%) |
| June 2024 | - | $94.85 M(-5.3%) |
| Mar 2024 | - | $100.20 M(+64.1%) |
| Dec 2023 | $61.07 M(-46.0%) | $61.07 M(-14.0%) |
| Sept 2023 | - | $71.01 M(-6.6%) |
| June 2023 | - | $76.06 M(-9.5%) |
| Mar 2023 | - | $84.09 M(-25.7%) |
| Dec 2022 | $113.20 M(+78.1%) | $113.20 M(+40.9%) |
| Sept 2022 | - | $80.36 M(-16.9%) |
| June 2022 | - | $96.66 M(-13.0%) |
| Mar 2022 | - | $111.06 M(+74.7%) |
| Dec 2021 | $63.56 M | $63.56 M(-27.0%) |
| Sept 2021 | - | $87.08 M(-20.2%) |
| June 2021 | - | $109.12 M(-18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $133.20 M(+7.4%) |
| Dec 2020 | $124.00 M(+106.2%) | $124.00 M(-9.0%) |
| Sept 2020 | - | $136.20 M(+2.0%) |
| June 2020 | - | $133.58 M(+59.7%) |
| Mar 2020 | - | $83.64 M(+39.1%) |
| Dec 2019 | $60.15 M(-44.2%) | $60.15 M(-31.8%) |
| Sept 2019 | - | $88.18 M(-16.1%) |
| June 2019 | - | $105.14 M(-24.9%) |
| Mar 2019 | - | $140.04 M(+30.0%) |
| Dec 2018 | $107.73 M(+174.9%) | $107.73 M(-15.5%) |
| Sept 2018 | - | $127.46 M(-0.3%) |
| June 2018 | - | $127.84 M(+152.4%) |
| Mar 2018 | - | $50.64 M(+29.2%) |
| Dec 2017 | $39.19 M(+27.9%) | $39.19 M |
| Dec 2016 | $30.65 M | - |
FAQ
- What is Xeris Biopharma Holdings annual working capital?
- What is the all time high annual working capital for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual working capital year-on-year change?
- What is Xeris Biopharma Holdings quarterly working capital?
- What is the all time high quarterly working capital for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly working capital year-on-year change?
What is Xeris Biopharma Holdings annual working capital?
The current annual working capital of XERS is $61.07 M
What is the all time high annual working capital for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual working capital is $124.00 M
What is Xeris Biopharma Holdings annual working capital year-on-year change?
Over the past year, XERS annual working capital has changed by -$52.13 M (-46.05%)
What is Xeris Biopharma Holdings quarterly working capital?
The current quarterly working capital of XERS is $71.79 M
What is the all time high quarterly working capital for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly working capital is $140.04 M
What is Xeris Biopharma Holdings quarterly working capital year-on-year change?
Over the past year, XERS quarterly working capital has changed by +$774.00 K (+1.09%)